Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment.
about
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An UpdateTicagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelorPharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function.Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.Ticagrelor for the treatment of peripheral arterial disease.Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5.Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes.Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirin.Metabolism of ticagrelor in patients with acute coronary syndromes
P2860
Q27006031-90CF2E21-DA4F-4952-95B9-DF58D4D69EA7Q34805121-1CAE4587-BDD8-49B7-BBDF-F60BAD836FF4Q36807413-9C50D8AB-CF5A-405F-A21D-8B72769BFC71Q37679896-64A10085-F4CC-4E9E-BEC9-CBC133489FEAQ38151563-9BF2CA98-3F11-42DA-91E3-8298FED8F27AQ38265669-F536DC0F-A25E-4F99-9BC4-7D1EFE07AD4CQ38974884-0016140D-318F-4756-80B0-B61157EFBF5AQ39147420-F6D26AA5-B02E-4A97-B8FB-3F35F15B6F94Q40072776-D8D96F1F-C268-4F9D-A78B-FF68A36A94FFQ41060485-4B350154-AF22-4DC0-8419-5AABFDE42290Q50786662-D071F073-322B-4BBC-A47E-05CEFC412BB7Q58799733-46C9D7A0-BFF8-44FA-899C-B26FB187C6FB
P2860
Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@en
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@nl
type
label
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@en
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@nl
prefLabel
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@en
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@nl
P2860
P356
P1476
Pharmacokinetics, pharmacodyna ...... with severe renal impairment.
@en
P2093
Kathleen Butler
Renli Teng
P2860
P304
P356
10.1177/0091270011415526
P577
2011-09-29T00:00:00Z